Global SWFI for Reconstitution of Lyophilized Drugs Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2021-2027

Sterile Water for Injection (SWFI) is sterile, nonpyrogenic, distilled water in a single dose container for intravenous administration after addition of a suitable solute. It may also be used as a dispensing container for diluent use.
SWFI are used for reconstitution of lyophilized drugs, diluent of injection solution and rinsing agent for endoscopy in various departments. SWFI for reconstitution of lyophilized drugs.
In this report, we only collect data of SWFI being sold as a part of set with LYO drug.
Asia-Pacific and Europe are the two largest consumption regions, with a consumption market share nearly 40% and 30%. North America is also an important sales region.
Market competition is intense. Baxter, Hospira (ICU Medical), Vetter, Otsuka, ROVI, Fresenius Kabi, etc. are the leaders of the industry, they hold key technologies and patents, with high-end customers.
The classification of SWFI for reconstitution of lyophilized drugs includes Vials and Ampoules and Pre-Filled Syringes. The sales proportion of Vials and Ampoules is over 95%.
SWFI for reconstitution of lyophilized drugs is widely used for vaccines, Biological Products, Bio-pharmaceutical. The most proportion of SWFI for reconstitution of lyophilized drugs is used for vaccine, the proportion is about 73%.

Market Analysis and Insights: Global SWFI for Reconstitution of Lyophilized Drugs Market
In 2020, the global SWFI for Reconstitution of Lyophilized Drugs market size was US$ 12 million and it is expected to reach US$ 18 million by the end of 2027, with a CAGR of 5.4% during 2021-2027.
Global SWFI for Reconstitution of Lyophilized Drugs Scope and Market Size
SWFI for Reconstitution of Lyophilized Drugs market is segmented by region, by country, company, type, application and by sales channels. Players, stakeholders, and other participants in the global SWFI for Reconstitution of Lyophilized Drugs market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by region, by country, company, type, application and by sales channels for the period 2016-2027.

Segment by Container, the SWFI for Reconstitution of Lyophilized Drugs market is segmented into
Vials and Ampoules
Pre-Filled Syringes


Segment by Application, the SWFI for Reconstitution of Lyophilized Drugs market is segmented into
Vaccine
Biological Products
Bio-Pharmaceutical

Regional and Country-level Analysis:
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
India
Southeast Asia
Australia
Rest of Asia-Pacific
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

Competitive Landscape

and SWFI for Reconstitution of Lyophilized Drugs Market Share Analysis
SWFI for Reconstitution of Lyophilized Drugs market competitive landscape provides details and data information by companies. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2016-2021. It also offers detailed analysis supported by reliable statistics on sale and revenue by players for the period 2016-2021. Details included are company description, major business, SWFI for Reconstitution of Lyophilized Drugs product introduction, recent developments, SWFI for Reconstitution of Lyophilized Drugs sales by region, type, application and by sales channel.

The major companies include:
Baxter
Hospira (ICU Medical)
Vetter
Otsuka
ROVI
Fresenius Kabi
Shijiazhuang No. 4 Pharmaceutical
Hikma
Kelun
Deo Gratias Parenteral